BioLineRx (BLRX) Net Income towards Common Stockholders Growth (1y) (2014 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | -58.11% |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | -95.76% |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | -290.15% |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 59.59% |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | -129.68% |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | -10.08% |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 1,228.66% |
| 10 | BioLineRx | 9.32 Bn | 9.30 Bn | 154,000.00 | -816.88% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -816.88% |
| Sep 30, 2025 | 54.15% |
| Jun 30, 2025 | 51.25% |
| Mar 31, 2025 | 49.61% |
| Dec 31, 2024 | 102.91% |
| Sep 30, 2024 | 70.31% |
| Jun 30, 2024 | 61.26% |
| Mar 31, 2024 | 62.81% |
| Dec 31, 2023 | -102.71% |
| Sep 30, 2023 | -67.23% |
| Jun 30, 2023 | -13.93% |
| Mar 31, 2023 | -53.60% |
| Dec 31, 2022 | -8.15% |
| Sep 30, 2022 | -13.52% |
| Jun 30, 2022 | -16.32% |
| Mar 31, 2022 | -15.76% |
| Dec 31, 2021 | -15.02% |
| Sep 30, 2021 | -37.05% |
| Jun 30, 2021 | -19.59% |
| Mar 31, 2021 | 19.93% |
| Dec 31, 2020 | 37.04% |
| Sep 30, 2020 | 25.71% |
| Jun 30, 2020 | 12.46% |
| Mar 31, 2020 | -27.74% |
| Dec 31, 2019 | -29.82% |
| Sep 30, 2019 | 4.10% |
| Jun 30, 2019 | -8.05% |
| Mar 31, 2019 | 21.24% |
| Dec 31, 2018 | 12.14% |
| Sep 30, 2018 | 12.34% |
| Jun 30, 2018 | -11.09% |
| Mar 31, 2018 | -29.14% |
| Dec 31, 2017 | -72.84% |
| Sep 30, 2017 | -59.97% |
| Jun 30, 2017 | -29.53% |
| Mar 31, 2017 | -33.31% |
| Dec 31, 2016 | -7.13% |
| Sep 30, 2016 | -25.82% |
| Jun 30, 2016 | 4.70% |
| Mar 31, 2016 | 14.35% |
| Dec 31, 2015 | -5.97% |
| Sep 30, 2015 | -92.85% |
| Jun 30, 2015 | -15.05% |
| Mar 31, 2015 | -16.40% |
| Dec 31, 2014 | -90.97% |
| Sep 30, 2014 | 31.12% |
| Jun 30, 2014 | 9.28% |
| Mar 31, 2014 | 36.89% |